Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000552672 | SCV000639311 | likely benign | Familial adenomatous polyposis 2 | 2024-11-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000571211 | SCV000662624 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-02-06 | criteria provided, single submitter | clinical testing | The c.349-5G>A intronic variant results from a G to A substitution 5 nucleotides upstream from coding exon 4 in the MUTYH gene. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing; however, direct evidence is insufficient at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Color Diagnostics, |
RCV000571211 | SCV000913006 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-06-30 | criteria provided, single submitter | clinical testing |